Dr Mark Edward Fenzl, DO | |
216 E Lima St, Forest, OH 45843-1118 | |
(419) 273-2553 | |
(419) 273-3337 |
Full Name | Dr Mark Edward Fenzl |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 216 E Lima St, Forest, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790993137 | NPI | - | NPPES |
P00681969 | Other | OH | RAILROAD CARE |
2902854 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 34.008871 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mark Edward Fenzl, DO 216 E Lima St, Forest, OH 45843-1118 Ph: (419) 273-2553 | Dr Mark Edward Fenzl, DO 216 E Lima St, Forest, OH 45843-1118 Ph: (419) 273-2553 |
News Archive
Porvair Sciences announces a new range of 96-well (square and round) capmats made from 100% pure silicone that has been conditioned for low bleed and ease of needle penetration when used with autosamplers.
Stroke patients who show little improvement in the first 24 hours after receiving thrombolytic (clot-dissolving) therapy are more likely to have poor outcomes or death at three months, according to a study in the October 20 JAMA.
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Stryker Corporation announced today that its Board of Directors has authorized the Company to repurchase up to $750 million of its common stock. The manner, timing and amount of any purchases will be determined by the Company's management based on their evaluation of market conditions, stock price and other factors and will be subject to regulatory considerations. Purchases may be made from time to time in the open market, in privately negotiated transactions or otherwise.
› Verified 1 days ago